Skip to main content

Table 1 Baseline clinical data of the randomized population with type 1 diabetes on MiniMedâ„¢ 780G insulin pump

From: Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMedâ„¢ 780G advanced hybrid closed loop system: a randomized clinical trial for adjunctive oral vildagliptin therapy during Ramadan fasting

Variable

Vildagliptin group (n = 25)

Control group (n = 25)

p value

Age (years)

 Mean ± SD

16.5 ± 3.5

17.1 ± 4.2

0.586

Gender, n (%)

 Male

13 (52)

11 (44)

0.571

 Female

12 (48)

14 (56)

Weight SDS

 Median (IQR)

0.25 (0.08–1.43)

0.31 (0.18–1.23)

0.892

BMI SDS

 Median (IQR)

1.21 (0.10–1.76)

1.17 (0.4–1.6)

0.899

Diabetes duration (years)

 Mean ± SD

7.52 ± 2.65

7.12 ± 2.45

0.582

AHCL therapy duration (years)

 Mean ± SD

1.93 ± 0.86

1.72 ± 0.75

0.362

  1. BMI body mass index, SDS standard deviation score, AHCL Advanced Hybrid Closed Loop System